Libera Bio 

Novel antibodies delivered to intracellular targets for new options in cancer

OWNER

Olivier Jarry (See Profile)


Sector

Cancer therapeutics

Stage

Prototyping, preclinical

Country

Spain


Only technology with in vivo POC of delivering mAb to intracellular targets

Already partnering with one large pharma and 3 mAb developers

Large number of potential targets and versatility to deliver other biologics.

Status

Approved

IP Type

Patent

Time

17 years

Countries

Austria
Belgium
Canada
China
Denmark
Finland
France
Germany
Italy
Japan
Netherlands
South Korea
Spain
Switzerland
USA
United Kingdom

Coverage

Structure and composition of nanocapsules. Manufacturing. Ligands.
Nanocapsules for intracellular distribution of antibodies.
Nanocapsules for intracellular distribution of KRAS antibodies.

Know more of this patent

View more

This information is confidential, do not share or copy.

You can visit their website or

Download the Pitch Deck
Other files:

Article in Nature

Nano‐Oncologicals A Tortoise Trail Reaching New Avenues

Molina-Crespo et al. Intracellular Delivery of an Antibody Targeting Gasdermin-B

Teijeiro-VAliño C. A multifunctional drug nanocarrier for efficient anticancer therapy

Business Development and Exits Strategy

Under evaluation at least till: 7th of April 2023

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar